116 related articles for article (PubMed ID: 1808119)
1. Biodistribution and imaging characteristics of iotrolan-carrying interdigitation-fusion vesicles.
Seltzer SE; Janoff AS; Blau M; Adams DF; Minchey SR; Boni LT
Invest Radiol; 1991 Nov; 26 Suppl 1():S169-71; discussion S175-6. PubMed ID: 1808119
[No Abstract] [Full Text] [Related]
2. Contrast material-carrying liposomes: biodistribution, clearance, and imaging characteristics.
Seltzer SE; Blau M; Herman LW; Hooshmand RL; Herman LA; Adams DF; Minchey SR; Janoff AS
Radiology; 1995 Mar; 194(3):775-81. PubMed ID: 7862978
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and clearance of contrast-carrying MREV liposomes.
White C; Slifkin M; Seltzer SE; Blau M; Adzamli IK; Adams DF
Invest Radiol; 1990 Oct; 25(10):1125-9. PubMed ID: 2079413
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution and excretion of iotrolan after intravenous and suboccipital injections in animals.
Weinmann HJ; Scholz P; Mützel W
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():206-10. PubMed ID: 2568796
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
Scholz P; Weinmann HJ; Mützel W; Staks T
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
[TBL] [Abstract][Full Text] [Related]
6. Human pharmacokinetics and modeling of the concentration-attenuation relationship of a new liposomal liver-specific contrast agent for CT.
Höglund P; Leander P; Hustvedt SO; Kloster Y; Børseth A
Acad Radiol; 1998 Apr; 5 Suppl 1():S47-8; discussion S60-2. PubMed ID: 9561041
[No Abstract] [Full Text] [Related]
7. Renal excretion and computed tomography enhancement of iotrolan and iopamidol in dogs.
Benness G; Evill C; Wilcox J; Hassam R; Arozoo E
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():88-90. PubMed ID: 2568815
[TBL] [Abstract][Full Text] [Related]
8. Distribution of liposome-encapsulated iodixanol in rat liver cells.
Kjeken R; Kindberg GM; Berg T
Biochem Pharmacol; 2000 Aug; 60(4):553-9. PubMed ID: 10874130
[TBL] [Abstract][Full Text] [Related]
9. Preclinical characterization of iopromide-carrying liposomes.
Krause W; Sachse A; Wagner S; Kollenkirchen U; Rössling G
Invest Radiol; 1991 Nov; 26 Suppl 1():S172-4; discussion S175-6. PubMed ID: 1808120
[No Abstract] [Full Text] [Related]
10. Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol.
Miyamoto Y; Tsujimoto T; Iwai K; Ishida K; Uchimoto R; Miyazawa T; Azuma H
Invest Radiol; 1995 Sep; 30(9):538-43. PubMed ID: 8537211
[TBL] [Abstract][Full Text] [Related]
11. Plasma level and renal excretion of iotrolan after lumbar injection in patients.
Weinmann HJ; Vogelsang H; Mützel W; Speck U
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():224-7. PubMed ID: 2568801
[TBL] [Abstract][Full Text] [Related]
12. CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles.
Torchilin VP; Frank-Kamenetsky MD; Wolf GL
Acad Radiol; 1999 Jan; 6(1):61-5. PubMed ID: 9891154
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study on vascular permeability and hemodynamics of nonionic dimeric contrast media (Iotrolan): a comparison to nonionic monomer on dynamic CT and angiography].
Sako M; Sugimoto K; Hirota S; Matsumoto S; Kuwata Y; Hasegawa Y; Tomita M; Murakami T; Kono M
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jan; 54(1):32-9. PubMed ID: 8121768
[TBL] [Abstract][Full Text] [Related]
14. Experimental urography in dogs: diagnostic quality and pharmacokinetic behavior of iotrolan in comparison to nonionic and ionic, monomeric contrast media.
Nauert C; Mützel W
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():82-7. PubMed ID: 2568814
[TBL] [Abstract][Full Text] [Related]
15. Clinical and nephrologic tolerance of iopromide and iotrolan in computed tomography.
Langer M; Langer R; Zwicker C; Speck U; Jänicke UA; Felix R
Invest Radiol; 1991 Nov; 26 Suppl 1():S83-5; discussion S88-91. PubMed ID: 1808156
[No Abstract] [Full Text] [Related]
16. A new liposomal contrast medium for CT of the liver. An imaging study in a rabbit tumour model.
Leander P
Acta Radiol; 1996 Jan; 37(1):63-8. PubMed ID: 8611327
[TBL] [Abstract][Full Text] [Related]
17. Interdigitation-fusion vesicles. A new approach for selective opacification of the RES.
Janoff AS; Minchey SR; Perkins WR; Boni LT; Seltzer SE; Adams DF; Blau M
Invest Radiol; 1991 Nov; 26 Suppl 1():S167-8; discussion S175-6. PubMed ID: 1808118
[No Abstract] [Full Text] [Related]
18. [Oral administration of intravenous contrast media: a tasty alternative to conventional oral contrast media in computed tomography].
Diederichs G; Franiel T; Asbach P; Romano V; Hamm B; Rogalla P
Rofo; 2007 Oct; 179(10):1061-7. PubMed ID: 17786895
[TBL] [Abstract][Full Text] [Related]
19. Iopromide-carrying liposomes as a contrast agent for the liver.
Krause W; Leike J; Schuhmann-Giampieri G; Sachse A; Schmiedl U; Strunk H
Acad Radiol; 1996 Aug; 3 Suppl 2():S235-7. PubMed ID: 8796571
[No Abstract] [Full Text] [Related]
20. Blood pool and liver enhancement in CT with liposomal lodixanol: comparison with lohexol.
Desser TS; Rubin DL; Muller H; McIntire GL; Bacon ER; Toner JL
Acad Radiol; 1999 Mar; 6(3):176-83. PubMed ID: 10898037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
